Gentian Violet for Hidradenitis Suppurativa

Recruiting in Palo Alto (17 mi)

Overseen byRita Pichardo-Geisinger, MD

Age: 18 - 65

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Phase 2

Waitlist Available

Sponsor: Wake Forest University Health Sciences

No Placebo Group

Prior Safety Data

Trial Summary

What is the purpose of this trial?This is a survey study being conducted to describe how subjects with Hidradenitis suppurativa (HS) respond to treatment with gentian violet. The study will rely primarily on qualitative survey responses and quantitative changes in skin appearance.

Eligibility Criteria

This trial is for adults with active Hidradenitis Suppurativa (HS), a skin condition. Participants must be willing to have one treatment of Gentian Violet and agree to a follow-up after one month. It's not suitable for children, those without current HS lesions, or individuals unable to evaluate their quality of life for the survey.

Inclusion Criteria

I have active HS and agree to one treatment and a follow-up in a month.

Exclusion Criteria

I am a child.

I can understand and respond to questions about my quality of life.

I do not have any active skin lesions.

Participant Groups

The study tests how effective Gentian Violet is in treating HS by examining changes in the skin and collecting patient feedback through surveys about their experience and results after treatment.

1Treatment groups

Experimental Treatment

Group I: Gentian Violet TreatmentExperimental Treatment1 Intervention

A single application of gentian violet will be topically applied to the site(s) of active HS involvement by a trained staff member. The sites will then be bandaged by staff and patients will be instructed about home maintenance procedures.